HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Galli Selected Research

Immunoglobulin G (IgG)

12/2021Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.
1/2021Rapid COVID-19 Screening Based on Self-Reported Symptoms: Psychometric Assessment and Validation of the EPICOVID19 Short Diagnostic Scale.
1/2021Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study.
1/2021Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
1/2021Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy.
1/2021Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine.
1/2015Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Galli Research Topics

Disease

45Infections
05/2022 - 03/2004
37COVID-19
05/2022 - 01/2020
18HIV Infections (HIV Infection)
12/2021 - 08/2003
11Acquired Immunodeficiency Syndrome (AIDS)
06/2021 - 12/2002
7Coinfection
11/2018 - 04/2011
6Disease Progression
01/2021 - 01/2005
6Vasculitis (Vasculitides)
01/2021 - 06/2011
5Chronic Hepatitis C
05/2021 - 02/2006
5Cryoglobulinemia
01/2021 - 11/2011
5Communicable Diseases (Infectious Diseases)
09/2020 - 01/2014
5Fatigue
08/2019 - 01/2010
4Liver Diseases (Liver Disease)
12/2021 - 11/2010
4Body Weight (Weight, Body)
06/2021 - 01/2005
4Rheumatoid Arthritis
01/2021 - 11/2017
4Viremia
01/2019 - 12/2010
3Fever (Fevers)
12/2021 - 01/2020
3Human Influenza (Influenza)
01/2021 - 04/2003
3Pneumonia (Pneumonitis)
12/2020 - 01/2020
3Respiratory Insufficiency (Respiratory Failure)
11/2020 - 05/2017
3Thrombocytopenia (Thrombopenia)
01/2020 - 11/2010
3Glomerulonephritis
08/2019 - 06/2011
3Peripheral Nervous System Diseases (PNS Diseases)
08/2019 - 12/2002
3Neoplasms (Cancer)
04/2013 - 12/2002
3Lipodystrophy
09/2008 - 08/2003
2Herpes Zoster
09/2022 - 10/2019
2Rheumatic Diseases (Rheumatism)
05/2021 - 01/2021
2Inflammation (Inflammations)
01/2021 - 07/2020
2Pain (Aches)
01/2021 - 02/2015
2Type 2 Diabetes Mellitus (MODY)
12/2020 - 07/2020
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
03/2020 - 01/2014
2Critical Illness (Critically Ill)
01/2020 - 10/2016
2Opportunistic Infections (Opportunistic Infection)
10/2019 - 12/2014
2Skin Ulcer
08/2019 - 06/2011
2Hepatitis B
01/2018 - 10/2017
2Arthralgia (Joint Pain)
03/2017 - 02/2015
2Purpura
03/2017 - 02/2015
2Fibrosis (Cirrhosis)
06/2015 - 04/2011
2Lymphopenia (Lymphocytopenia)
12/2010 - 06/2010
2Hypersensitivity (Allergy)
01/2007 - 06/2003
1Crohn Disease (Crohn's Disease)
09/2022
1Venous Thromboembolism
04/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022
1Alcoholism (Alcohol Abuse)
12/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021
1Wounds and Injuries (Trauma)
07/2021

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
10/2020 - 08/2003
9Antiviral Agents (Antivirals)IBA
12/2021 - 06/2015
8VaccinesIBA
09/2022 - 08/2007
8InterferonsIBA
11/2016 - 02/2006
7Immunoglobulin G (IgG)IBA
12/2021 - 01/2015
7Biological ProductsIBA
01/2021 - 09/2014
7Ribavirin (Virazole)FDA LinkGeneric
02/2015 - 02/2006
6RNA (Ribonucleic Acid)IBA
11/2021 - 03/2005
6Rituximab (Mabthera)FDA Link
05/2021 - 06/2011
5CytokinesIBA
01/2022 - 04/2003
5AntibodiesIBA
02/2021 - 01/2013
5Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2010
4Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021 - 12/2020
4Indicators and Reagents (Reagents)IBA
10/2020 - 01/2016
4Protease Inhibitors (Protease Inhibitor)IBA
10/2014 - 05/2004
3COVID-19 VaccinesIBA
05/2022 - 01/2021
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2003
3BNT162 VaccineIBA
12/2021 - 01/2021
3Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2021 - 03/2012
3LipidsIBA
06/2021 - 03/2005
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 06/2019
3LopinavirFDA Link
01/2021 - 03/2004
3tocilizumab (atlizumab)FDA Link
01/2021 - 01/2020
3remdesivirIBA
01/2021 - 01/2020
3Alanine Transaminase (SGPT)IBA
11/2020 - 11/2010
3EnzymesIBA
01/2020 - 02/2006
3nitinolIBA
08/2019 - 01/2010
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2019
2mRNA VaccinesIBA
01/2022 - 01/2021
2Messenger RNA (mRNA)IBA
12/2021 - 01/2021
2dolutegravirIBA
06/2021 - 01/2021
2Ritonavir (Norvir)FDA Link
01/2021 - 01/2021
2AntigensIBA
01/2021 - 04/2003
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 04/2010
2Vitamin DFDA LinkGeneric
01/2021 - 04/2011
2Darunavir (Prezista)FDA Link
01/2021 - 01/2014
2Dipeptidyl-Peptidase IV InhibitorsIBA
12/2020 - 07/2020
2CreatinineIBA
01/2020 - 01/2013
2Antirheumatic Agents (DMARD)IBA
11/2019 - 11/2017
2GoldIBA
07/2019 - 03/2019
2Nevirapine (Viramune)FDA Link
11/2018 - 01/2018
2Interleukin-7 (Interleukin 7)IBA
12/2010 - 06/2004
2tucaresolIBA
09/2005 - 08/2004
12-mercaptopurineIBA
09/2022
1Interleukin-8 (Interleukin 8)IBA
12/2021
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2021
1SuspensionsIBA
07/2021
1RacivirIBA
06/2021
1Rilpivirine (TMC-278)IBA
06/2021

Therapy/Procedure

23Therapeutics
09/2022 - 04/2003
12Highly Active Antiretroviral Therapy (HAART)
01/2016 - 12/2002
4Art Therapy
01/2021 - 08/2003
3Artificial Respiration (Mechanical Ventilation)
11/2020 - 05/2017
3Drug Therapy (Chemotherapy)
07/2014 - 12/2002
2Off-Label Use
01/2021 - 01/2020